Zealand Pharma A/S. - ADR
|Market Cap (Intraday)||1.46B|
|2yr Forward PE||N/A|
Zealand Pharma A/S Stock, NASDAQ:ZEAL
Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.